| 标题 |
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation |
| 网址 | |
| DOI | |
| 其它 |
期刊:Signal Transduction and Targeted Therapy 作者:Dan‐Yun Ruan; Haoxiang Wu; Ye Xu; Pamela N. Münster; Yanhong Deng; et al 出版日期:2025-06-16 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)